Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Piva

Showing results (41-50 of 114) with videos related to

Pageof 12
Sort By:
European Urology|June 13, 2018
Re: Gut Microbiome Influences Efficacy of PD-1-based Immunotherapy Against Epithelial TumorsMatteo Santoni, Francesco Piva, Alessandro Conti, et al.
Human Psychopharmacology|July 1, 2011
Bioinformatic analyses to select phenotype affecting polymorphisms in HTR2C geneFrancesco Piva, Matteo Giulietti, Luisa Baldelli, et al.
Bioinformatics (Oxford, England)|December 31, 2021
LipidOne: user-friendly lipidomic data analysis tool for a deeper interpretation in a systems biology scenarioRoberto Maria Pellegrino, Matteo Giulietti, Husam B R Alabed, et al.
European Urology|September 4, 2015
Re: epithelial-to-mesenchymal transition in renal neoplasmsRodolfo Montironi, Matteo Santoni, Marina Scarpelli, et al.
Database : the Journal of Biological Databases and Curation|November 25, 2020
MetaTropismDB: a database of organ-specific metastasis induced by human cancer cell lines in mouse modelsMatteo Giulietti, Marco Bastianoni, Monia Cecati, et al.
Environmental Health Perspectives|January 6, 2006
Use of the land snail Helix aspersa as sentinel organism for monitoring ecotoxicologic effects of urban pollution: an integrated approachFrancesco Regoli, Stefania Gorbi, Daniele Fattorini, et al.
Immunotherapy|November 27, 2018
Risk of fatigue in cancer patients treated with anti programmed cell death-1/anti programmed cell death ligand-1 agents: a systematic review and meta-analysisMatteo Santoni, Alessandro Conti, Sebastiano Buti, et al.
European Urology|March 8, 2016
Re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4Francesco Piva, Matteo Santoni, Marina Scarpelli, et al.
Molecular Diagnosis & Therapy|March 5, 2016
Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer TherapyFrancesco Piva, Matteo Giulietti, Matteo Santoni, et al.
Expert Opinion on Investigational Drugs|February 18, 2021
An update on investigational therapies that target STAT3 for the treatment of cancerMatteo Santoni, Francesca Miccini, Alessia Cimadamore, et al.
Pageof 12

Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
European Urology|June 13, 2018
Re: Gut Microbiome Influences Efficacy of PD-1-based Immunotherapy Against Epithelial TumorsMatteo Santoni, Francesco Piva, Alessandro Conti, et al.
Human Psychopharmacology|July 1, 2011
Bioinformatic analyses to select phenotype affecting polymorphisms in HTR2C geneFrancesco Piva, Matteo Giulietti, Luisa Baldelli, et al.
Bioinformatics (Oxford, England)|December 31, 2021
LipidOne: user-friendly lipidomic data analysis tool for a deeper interpretation in a systems biology scenarioRoberto Maria Pellegrino, Matteo Giulietti, Husam B R Alabed, et al.
European Urology|September 4, 2015
Re: epithelial-to-mesenchymal transition in renal neoplasmsRodolfo Montironi, Matteo Santoni, Marina Scarpelli, et al.
Database : the Journal of Biological Databases and Curation|November 25, 2020
MetaTropismDB: a database of organ-specific metastasis induced by human cancer cell lines in mouse modelsMatteo Giulietti, Marco Bastianoni, Monia Cecati, et al.
Environmental Health Perspectives|January 6, 2006
Use of the land snail Helix aspersa as sentinel organism for monitoring ecotoxicologic effects of urban pollution: an integrated approachFrancesco Regoli, Stefania Gorbi, Daniele Fattorini, et al.
Immunotherapy|November 27, 2018
Risk of fatigue in cancer patients treated with anti programmed cell death-1/anti programmed cell death ligand-1 agents: a systematic review and meta-analysisMatteo Santoni, Alessandro Conti, Sebastiano Buti, et al.
European Urology|March 8, 2016
Re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4Francesco Piva, Matteo Santoni, Marina Scarpelli, et al.
Molecular Diagnosis & Therapy|March 5, 2016
Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer TherapyFrancesco Piva, Matteo Giulietti, Matteo Santoni, et al.
Expert Opinion on Investigational Drugs|February 18, 2021
An update on investigational therapies that target STAT3 for the treatment of cancerMatteo Santoni, Francesca Miccini, Alessia Cimadamore, et al.
Pageof 12